Contract Services Contract Research

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™

Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...

 September 30, 2022 | News

Redbud raises $10M in series A round as CRO focusing on science-driven clinical development

Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...

 September 13, 2022 | News

WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility

WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...

 September 12, 2022 | News

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...

 September 05, 2022 | News

Viva Biotech Announced 2022 Interim Results

Financial Highlights for the 6 months ended June 30, 2022: Revenue amounted to RMB1,108.7 million, representing a year-on-year ("YoY") increas...

 August 30, 2022 | News

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...

 July 14, 2022 | News

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it...

 May 20, 2022 | News

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

The Summit will feature insights from leading Novotech experts tapping decades of oncology clinical experience in the APAC region. They include:- Dr. Raman...

 May 12, 2022 | News

Novotech Acquires US CRO NCGS, Expands Global Expertise

Novotech CEO Dr. John Moller said "We are very pleased to acquire such an impressive company with a strong history of quality and delivery in the United St...

 May 05, 2022 | News

Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza

Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digita...

 April 14, 2022 | News

National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development

The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...

 February 07, 2022 | News

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...

 January 18, 2022 | News

Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA

Merck, a leading science and technology company, has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufac...

 January 07, 2022 | News

NovAliX acquires Sanofi site in Strasbourg and creates Guy Ourisson Research Campus

NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces the first stage in its development project t...

 January 07, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close